Answers are grounded in this paper and cite their sources.
Evidence for genetic control of susceptibility to Graves disease was sought using the human major histocompatibility (HL-A) antigens as genetic markers. HL-A typing and assays for antithyroglobulin (anti-Tg) and anti-(thyroid)-microsomal (anti-M) autoantibodies were performed on 62 unrelated Caucasian patients with Graves' disease and 113 normal unrelated Caucasian controls. The frequency of the HL-A8 antigen in the patient population was increased to 47% compared to 21% in controls (p < 0.0009) and 0% in a previously reported group of patients with post irradiation Graves' disease. The findings demonstrate that the HL-A antigens may be useful genetic markers of disease susceptibility and, in fact, may represent markers of different pathogenetic processes. It is proposed that histocompatibility linked immune response genes may provide a common explanation for the reported associations observed between thyroidal disease susceptibility and the species major histocompatibility locus in both the present human study and in previous murine studies.
No takes yet. Share an insight, caveat, or question.
Grumet et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: